Amgen Inc (AMGN)
Pretax margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | 7,855,000 | 7,346,000 | 6,701,000 | 8,133,000 | 9,138,000 |
Revenue | US$ in thousands | 25,568,000 | 51,272,000 | 50,799,000 | 25,424,000 | 23,362,000 |
Pretax margin | 30.72% | 14.33% | 13.19% | 31.99% | 39.11% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $7,855,000K ÷ $25,568,000K
= 30.72%
AMGEN Inc.'s pretax margin has fluctuated over the past five years. The company experienced a gradual decline in pretax margin from 39.11% in 2019 to 25.79% in 2021. However, there was a slight improvement in 2022 before reaching 27.86% in 2023. The pretax margin indicates how efficiently the company is generating profits before accounting for taxes relative to its revenue. The fluctuations in AMGEN's pretax margin suggest changes in its operational efficiency, cost management, and pricing strategies over the years. Further analysis and comparison with industry peers would provide a more comprehensive understanding of AMGEN's financial performance.
Peer comparison
Dec 31, 2023